Tag

Vaccine Manufacturing

Texas A&M Biocorridor offers veterans an opportunity to continue serving and protecting the nation

March 26, 2015

Workforce development is essential for continued growth of the Texas A&M Biocorridor. The National Center for Therapeutics Manufacturing (NCTM) is providing a specialized training program to transition veterans into the skilled biotechnology workforce.

Texas A&M Health Science Center solidifies growth trajectory with unprecedented research expenditures milestone

January 15, 2015

With an unprecedented 34 percent increase in 2014, Texas A&M Health Science Center has crossed the $100 million threshold in total annual research expenditures, which includes a nearly 68 percent increase in funding from federal sources.

Protecting Our Nation: Pandemic Influenza Vaccine Facility

November 4, 2014

Texas Governor Rick Perry, Texas A&M University System Chancellor John Sharp, Texas A&M Health Science Center CEO Brett Giroir, M.D., and officials from the U.S. Department of Health and Human Services (HHS), State of Texas and biopharmaceutical company GSK dedicated a national pandemic influenza vaccine manufacturing facility in Bryan, Texas, which when complete will serve as an anchor for the Texas A&M Biocorridor – a rapidly evolving hub of economic development and scientific discovery that is swiftly positioning Texas as the third coast in biotechnology.

Texas A&M dedicates national pandemic influenza vaccine manufacturing facility, on track for 2016 start-up phase

September 18, 2014

Texas Governor Rick Perry, Texas A&M University System Chancellor John Sharp, Texas A&M Health Science Center CEO Brett Giroir, M.D., and officials from the U.S. Department of Health and Human Services (HHS), State of Texas and biopharmaceutical company GSK today dedicated a national pandemic influenza vaccine manufacturing facility in Bryan, Texas, which when complete will serve as an anchor for the Texas A&M Biocorridor.

Editorial: Call for a roadmap to manage the Ebola (or the next public health) outbreak

August 21, 2014

Dr. Gerald Parker, vice president for public health preparedness and response, offers a roadmap for managing the next Ebola, or any global public health threat, whether naturally occurring or a deliberate attack.